Ivosidenib

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 399 publications

Efficacy and safety of ivosidenib-based therapy in 16 patients with IDH1-mutated acute myeloid leukemia

Efficacy and safety of ivosidenib-based therapy in 16 patients with IDH1-mutated acute myeloid leukemia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Health care resource utilization and costs in patients with acute myeloid leukemia treated with posttransplant maintenance therapy.

Health care resource utilization and costs in patients with acute myeloid leukemia treated with posttransplant maintenance therapy.

Journal: Journal of managed care & specialty pharmacy

Published: July 27, 2026

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; camizestrant for breast cancer, ivosidenib for biliary tract cancer, subcutaneous isatuximab and talquetamab plus teclistamab for multiple myeloma, isotretinoin for neuroblastoma, selpercatinib for pediatric RET-altered tumors, tafasitamab for lymphoma, and tislelizumab and durvalumab for gastric cancer.

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; camizestrant for breast cancer, ivosidenib for biliary tract cancer, subcutaneous isatuximab and talquetamab plus teclistamab for multiple myeloma, isotretinoin for neuroblastoma, selpercatinib for pediatric RET-altered tumors, tafasitamab for lymphoma, and tislelizumab and durvalumab for gastric cancer.

Journal: International journal of clinical oncology

Published: June 30, 2026

Host systemic metabolism and cancer metabolic vulnerabilities: mechanisms and therapeutic opportunities.

Host systemic metabolism and cancer metabolic vulnerabilities: mechanisms and therapeutic opportunities.

Journal: Frontiers in oncology

Published: June 01, 2026

Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors.

Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

MechAInistic: A Reviewer-Supervised Multi-Agent LLM System for Auditable Mechanistic Drug-Hypothesis Generation.

MechAInistic: A Reviewer-Supervised Multi-Agent LLM System for Auditable Mechanistic Drug-Hypothesis Generation.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

MechAInistic: An LLM-guided Multi-Agent System for Reasoning over Genome-Scale Constraint-Based Metabolic Models.

MechAInistic: An LLM-guided Multi-Agent System for Reasoning over Genome-Scale Constraint-Based Metabolic Models.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

Long-term (74-month) efficacy and safety of ivosidenib and azacitidine in an elderly patient with mutated IDH1 acute myeloid leukemia: insights from a case report.

Long-term (74-month) efficacy and safety of ivosidenib and azacitidine in an elderly patient with mutated IDH1 acute myeloid leukemia: insights from a case report.

Journal: Postgraduate medicine

Published: May 11, 2026

Controversies in the Management of AML in Older Patients: A Canadian Perspective.

Controversies in the Management of AML in Older Patients: A Canadian Perspective.

Journal: Current oncology (Toronto, Ont.)

Published: May 07, 2026

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.

Journal: Current oncology (Toronto, Ont.)

Published: May 07, 2026

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Journal: Leukemia research

Published: April 14, 2026

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

Journal: Leukemia

Published: April 12, 2026

Showing 1-12 of 399

Last Updated: 09/26/2026